Tumorigenesis and Neoplastic Progression Yin Yang 1 Plays an Essential Role in Breast Cancer and Negatively Regulates p 27
暂无分享,去创建一个
Qingyuan Zhang | Ming Lei | Suzy V. Torti | Wei Wang | Steven A. Akman | Lance D. Miller | L. Miller | S. Torti | Qiang Zhang | S. Akman | H. Hatcher | T. Kute | Guangchao Sui | Zhiyong Deng | Meimei Wan | Weiwei Huang | Guangchao Sui | Qiang Zhang | Qingyuan Zhang | Timothy E. Kute | Meimei Wan | Heather Hatcher | Jingxuan Wang | Daniel B. Stovall | Gregory B. Russell | Paul D. Cao | Jing-xuan Wang | Weiwei Huang | M. Lei | Zhiyong Deng | D. B. Stovall | Wen Wang | G. Russell
[1] L. Miller,et al. Yin Yang 1 contains G-quadruplex structures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase 1 , 2011, Nucleic acids research.
[2] Yang Shi,et al. Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.
[3] E. Moran,et al. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. , 1995, Genes & development.
[4] L. Khachigian,et al. Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 Assembly , 2007, Circulation research.
[5] R. Roberts. Faculty Opinions recommendation of mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. , 2007 .
[6] C. Deng,et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation , 2012, Oncogene.
[7] Goberdhan P Dimri,et al. Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. , 2007, Cancer research.
[8] T. Kute,et al. Measurement of Glut-1 Expression Using Tissue Microarrays to Determine a Race Specific Prognostic Marker for Breast Cancer , 2005, Breast Cancer Research and Treatment.
[9] Michele Pagano,et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.
[10] M. Whiteley,et al. The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. , 1998, Molecular cell.
[11] Kazushi Inoue,et al. The oncogenic role of Yin Yang 1. , 2011, Critical reviews in oncogenesis.
[12] T. Kute,et al. Measurement of PTEN expression using tissue microarrays to determine a race-specific prognostic marker in breast cancer. , 2007, Archives of pathology & laboratory medicine.
[13] Yosef Yarden,et al. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer , 2000, Oncogene.
[14] T. Yeatman,et al. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. , 2008, Cancer research.
[15] Yang Shi,et al. Gene silencing by a DNA vector-based RNAi technology. , 2005, Methods in molecular biology.
[16] Yudi Pawitan,et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients , 2006, Breast Cancer Research.
[17] Michael T. McManus,et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.
[18] M. Olivé,et al. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.
[19] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Bonavida,et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.
[21] D. Spandidos,et al. Yin Yang 1 expression in human tumors , 2010, Cell cycle.
[22] P. Kang,et al. Interaction between YY1 and the Retinoblastoma Protein , 2001, The Journal of Biological Chemistry.
[23] S. Horvath,et al. Expression of transcription factor Yin Yang 1 in prostate cancer. , 2005, International journal of oncology.
[24] L. Kopelovich,et al. The epigenome as a target for cancer chemoprevention. , 2003, Journal of the National Cancer Institute.
[25] F. Lovat,et al. p27kip1 Controls Cell Morphology and Motility by Regulating Microtubule-Dependent Lipid Raft Recycling , 2010, Molecular and Cellular Biology.
[26] W. Hahn,et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.
[27] Joanna R. Morris,et al. BRCA1 methylation: a significant role in tumour development? , 2002, Seminars in cancer biology.
[28] Jacques Boniver,et al. The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors , 2008, Breast Cancer Research.
[29] S. Weitzman,et al. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc , 2008, Oncogene.
[30] Yi Zhang,et al. Hierarchical recruitment of polycomb group silencing complexes. , 2004, Molecular cell.
[31] S. Grossman,et al. Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.
[32] S. Bates,et al. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.
[33] S. Cramer,et al. Yin Yang 1 Regulates the Transcriptional Activity of Androgen Receptor , 2009, Oncogene.
[34] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Seto,et al. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.
[36] L. Hengst,et al. p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.
[37] M. Tomayko,et al. Determination of subcutaneous tumor size in athymic (nude) mice , 2004, Cancer Chemotherapy and Pharmacology.
[38] Jeng-Shin Lee,et al. Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.
[39] Jeremy J. W. Chen,et al. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1. , 2007, Cancer research.
[40] Jayanta Debnath,et al. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.
[41] N. Bonini,et al. Transcription factor YY1 functions as a PcG protein in vivo , 2003, The EMBO journal.
[42] W. Forrester,et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] Mina J. Bissell,et al. Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets , 2008, PloS one.
[44] T. Ekström,et al. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. , 2004, Biochemical and biophysical research communications.
[45] D. A. Engel,et al. Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB , 1995, Journal of virology.
[46] S. Isom,et al. The podosome marker protein Tks5 regulates macrophage invasive behavior , 2011, Cytoskeleton.
[47] Andrew P Feinberg,et al. An integrated epigenetic and genetic approach to common human disease. , 2004, Trends in genetics : TIG.
[48] Pascale Jackers,et al. Yin Yang 1 Cooperates with Activator Protein 2 to Stimulate ERBB2 Gene Expression in Mammary Cancer Cells* , 2005, Journal of Biological Chemistry.
[49] Guangchao Sui,et al. PIASy-Mediated Sumoylation of Yin Yang 1 Depends on Their Interaction but Not the RING Finger , 2007, Molecular and Cellular Biology.
[50] Yu Pan,et al. MDM2 Promotes Ubiquitination and Degradation of MDMX , 2003, Molecular and Cellular Biology.
[51] C. Deng,et al. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution , 2006, Nucleic acids research.
[52] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[53] Guangchao Sui,et al. The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy , 2009 .
[54] I. Ellis,et al. Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification , 2009, Breast Cancer Research.
[55] G. Lyons,et al. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. , 2004, Genes & development.
[56] Giancarlo Castellano,et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression , 2009, Cell cycle.
[57] Hong Sun,et al. p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 , 1999, Current Biology.
[58] A. Thompson,et al. p53 mutation, deprivation and poor prognosis in primary breast cancer , 2010, British Journal of Cancer.
[59] J. Slingerland,et al. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer , 2003, Breast Cancer Research.
[60] Mina J Bissell,et al. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.
[61] N. Normanno,et al. Additive effects of c‐erbB‐2, c‐Ha‐ras, and transforming growth factor‐α genes on in vitro transformation of human mammary epithelial cells , 1992, Molecular carcinogenesis.
[62] J. Sinclair,et al. Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death. , 2005, European journal of cell biology.
[63] Wen‐Ming Yang,et al. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[64] J. Ericsson,et al. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[65] Jianfeng Xu,et al. Open Access RESEARCH , 2010 .